BetterLife Provides Important Update on its Australian Clinical Study Design
28 oct. 2020 08h00 HE
|
BetterLife Pharma
Vancouver, Oct. 28, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company preparing human clinical trials of AP-003, its interferon alpha 2b...
UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta
28 oct. 2020 05h00 HE
|
BetterLife Pharma
NEW YORK CITY, Oct. 28, 2020 (GLOBE NEWSWIRE) -- UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta The Chief...
BETTERLIFE PHARMA ANNOUNCES UP TO $5.0 MILLION PRIVATE PLACEMENT OFFERING OF SPECIAL WARRANTS
19 oct. 2020 08h00 HE
|
BetterLife Pharma
VANCOUVER, Oct. 19, 2020 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART,...
BetterLife Announces VirTrial as Clinical Trial Patient Monitoring Partner
08 oct. 2020 08h00 HE
|
BetterLife Pharma
VANCOUVER, Oct. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it...
BetterLife Receives FINRA Approval and Resumes Trading on the OTC Markets
30 sept. 2020 07h30 HE
|
BetterLife Pharma
VANCOUVER, Sept. 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that,...
BetterLife Scales up Manufacturing of AP-003 (Interferon Alpha 2b) to Prepare for Clinical Trials
17 sept. 2020 07h30 HE
|
BetterLife Pharma
VANCOUVER, Sept. 17, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced it has...
BetterLife CEO Interview on Canadian Stock Exchange Podcast Discussing Recent Advancements Now Live
09 sept. 2020 07h30 HE
|
BetterLife Pharma
VANCOUVER, Sept. 09, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced that Company...
BetterLife Pharma Engages Hybrid Financial Ltd.
08 sept. 2020 07h30 HE
|
BetterLife Pharma
VANCOUVER, Sept. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) is pleased to announce that it has retained Hybrid...
BetterLife Pharma Announces Dr. Eleanor Fish to Retain Role as Key Scientific Advisor Following Invitation to Join Government COVID-19 Task Force
02 sept. 2020 07h30 HE
|
BetterLife Pharma
Vancouver, Sept. 02, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company, today announced that...
BetterLife Resumes Trading Following CSE Merger Ratification with Altum Pharmaceuticals
01 sept. 2020 07h30 HE
|
BetterLife Pharma
Vancouver, Sept. 01, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) is pleased to announce that it has received confirmation...